Intellia Therapeutics listed its stock on the Nasdaq exchange.
9 reports, 4 independent
Updated Sep 25
Gone quiet
- Reports
- 9
- Developments
- 2
- Repetition
- 78%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Intellia Therapeutics listed its stock on the Nasdaq exchange.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Intellia Therapeutics trades on the Nasdaq exchange.1 source
Intellia Therapeutics completed its stock listing on Nasdaq.1 source
Keep exploring
The entities involved
-
Intellia Therapeutics
It is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system.
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
Related events
- Intellia Therapeutics and BeyondSpring are identified as small-cap healthcare companies.
- Intellia Therapeutics and Neurogene are identified as small-cap healthcare companies.
- Intellia Therapeutics and Spyre Therapeutics, Inc. are identified as healthcare companies competing for investment.
- Intellia Therapeutics and BeyondSpring Inc. are identified as small-cap healthcare companies.
- INmune Bio Inc. listed its shares on the stock exchange on July 9, 2026.
Coverage
Newest first; wire copies grouped- dailypolitical.com
- tickerreport.com
- fool.com
- tickerreport.com
- dailypolitical.com
- themarketsdaily.com